MedPath

Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
Interventions
Device: Dual Action Pneumatic Compression Device
Device: Standard Compression Garments
Registration Number
NCT02015221
Lead Sponsor
Tactile Medical
Brief Summary

The purpose of this study is to determine the ease of use and comfort of the ACTitouch dual action pneumatic compression device in patients with unilateral or bilateral chronic venous insufficiency (CVI) with or without venous leg ulcers, as compared to standard compression.

Detailed Description

Subjects will be randomized to receive either the ACTitouch system or standard compression garments, and will respond to symptom surveys and quality of life surveys to assess comfort and ease of use of each. These will be conducted at Baseline, at Day 15 and Day 30.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Diagnosis of unilateral or bilateral CVI with or without leg ulcers
  • Documented history of low adherence to compression garment therapy
  • CEAP classification C3-C6
  • Leg circumferences within the following ranges: Ankle 12-44cm, calf 22-6m, below the knee 22-68cm
Exclusion Criteria
  • History of skin sensitivity to any of the components of ACTitouch or compression garments
  • History of acute (deep vein thrombosis) DVT or (pulmonary embolism) PE within the last 3 months
  • Ankle Brachial Index (ABI) < 0.8
  • Acute thrombophlebitis
  • History of pulmonary edema or decompensated congestive heart failure
  • Currently has an active infection of the skin such as cellulitis requiring antibiotics
  • Poorly controlled diabetes with an HbA1c value of >10%
  • Exhibits any condition which, according to the PI, justifies the subjects exclusion from the study, such as a medical condition where an increase in venous or lymphatic return is undesirable.
  • Subjects with open ulcers must be able to follow their care regimen for ulcer healing concurrently with the assigned study regimen.
  • Participating in another clinical trial
  • Changes to medications that affect edema within the last 30 days
  • Currently pregnant or trying to become pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACTitouchDual Action Pneumatic Compression DeviceACTitouch in sustained gradient compression mode during all waking hours (at least 10 hours per day) and intermittent pneumatic compression mode for 2 hours each day.
Standard Compression GarmentsStandard Compression GarmentsStandard Compression Garments of compression levels 30mmHg to 40mmHg during all waking hours each day.
Primary Outcome Measures
NameTimeMethod
Ease of Use and Comfort for Subjects Using the ACTitouch System.30 days

Ease of application and removal (donning and doffing) the treatment at the baseline visit. Comfort of treatment after the treatment was first applied.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

Empire Orthopedic Center

๐Ÿ‡บ๐Ÿ‡ธ

Colton, California, United States

Long Beach VA Healthcare System

๐Ÿ‡บ๐Ÿ‡ธ

Long Beach, California, United States

Jobst Vascular Institute

๐Ÿ‡บ๐Ÿ‡ธ

Toledo, Ohio, United States

Associated Foot and Ankle Specialists, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Stony Brook Vein Center

๐Ÿ‡บ๐Ÿ‡ธ

Stony Brook, New York, United States

University Hospitals Case Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Ohio Health System

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

VA Loma Linda Healthcare System

๐Ÿ‡บ๐Ÿ‡ธ

Loma Linda, California, United States

Greenville Hospital System

๐Ÿ‡บ๐Ÿ‡ธ

Greenville, South Carolina, United States

Park Nicollet Heart and Vascular Center

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis, Minnesota, United States

University of California, San Diego

๐Ÿ‡บ๐Ÿ‡ธ

La Jolla, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath